Medical News

Leukemia, or cancer of the bone marrow, strikes some 700 Belgians each year. Researchers are still searching for the cause of a number of forms of leukemia, including T-cell acute lymphoblastic leukemia, or T-ALL. Now, VIB scientists connected to the Katholieke Universiteit Leuven have identified a new player in the development of some 10% of the T-ALL cases: MYB. The researchers have discovered that patients in this group have a duplication of the MYB gene, which increases MYB concentrations. Further research has indicated that MYB might well be an important target for therapies for this group of T-ALL patients……..

Original post by Health news from medicineworld.org

Leukemia, or cancer of the bone marrow, strikes some 700 Belgians each year. Researchers are still searching for the cause of a number of forms of leukemia, including T-cell acute lymphoblastic leukemia, or T-ALL. Now, VIB scientists connected to the Katholieke Universiteit Leuven have identified a new player in the development of some 10% of the T-ALL cases: MYB. The researchers have discovered that patients in this group have a duplication of the MYB gene, which increases MYB concentrations. Further research has indicated that MYB might well be an important target for therapies for this group of T-ALL patients……..

Original post by Health news from medicineworld.org